From Name:
From Email:
To Name:
To Email:

Optional Message:


Cancer genomes let drugmakers get personal

from Technology Review

A growing effort to personalize cancer medicine tries to link existing drugs to patients based on the specific genetic and molecular anomalies of a patient's cancer. But H3 Biomedicines, a startup in Cambridge, Mass., wants to personalize cancer drugs from the beginning by designing drugs to target specific patient populations. more


Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063